Capital Research Global Investors
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1422848
Los Angeles, CA
Position in TMO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,169,918,660
+$480,879,276 QoQ
Shares Held
4,414,621
+51.5% QoQ
Ownership
1.19%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.8010474738375.ToString("F0")%
Shared 0.ToString("F0")%
None 0.19895252616249504.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Capital Research Global Investors holds $4,311,389,109 across 6 Diagnostics & Research names. TMO ranks #1 (50.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
4,414,621 | $2,169,918,660 | |
| 2 | DHR |
Danaher Corp /De/
|
8,897,773 | $1,687,017,760 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
781,345 | $439,029,942 | |
| 4 | WGS |
GeneDx Holdings Corp.
|
151,055 | $9,700,752 | |
| 5 | QGEN |
Qiagen N.V.
|
119,998 | $4,804,719 | |
| 6 | RVTY |
Revvity, Inc.
|
10,470 | $917,276 |
All Filings in TMO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,169,918,660 | 4,414,621 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,689,039,384 | 2,914,901 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,533,954,323 | 3,162,662 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,203,131,378 | 5,433,659 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,788,127,787 | 7,612,797 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,120,599,286 | 7,920,726 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,064,655,073 | 8,187,683 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,555,223,582 | 8,237,294 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,715,436,355 | 8,113,137 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,240,807,215 | 7,989,614 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,782,343,683 | 7,472,477 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,178,148,818 | 6,091,325 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,420,071,798 | 5,933,813 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,941,985,503 | 7,158,266 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,441,357,334 | 8,756,792 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,750,730,431 | 8,744,534 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,132,459,672 | 8,689,511 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $6,308,108,311 | 9,454,032 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,282,492,612 | 9,245,957 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,570,747,912 | 9,060,495 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,041,163,207 | 8,854,821 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,627,936,981 | 9,935,886 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,111,645,259 | 11,577,381 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,225,735,536 | 11,662,349 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,342,695,641 | 11,786,656 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||